Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Non-Traumatic Rhabdomyolysis
NCT06429982Phase 1Recruiting
- Sponsor
- Children's National Research Institute
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in rhabdomyolysis comparing Dexamethasone Group with Placebo Group (2 arms). Primary endpoints: Length of Hospital Stay at 1 year, Muscle breakdown at 1 year and 1 more. Started Oct 2024; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
rhabdomyolysis
Beyond the preview
Go deeper on NCT06429982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06429982.